Showing results (531-540 of 1,183) with videos related to
Sort By:
Pageof 119
Growth Factors (Chur, Switzerland)|October 30, 2020
Heparin-binding epidermal growth factor (EGF)-like growth factor in pediatric patients with type 1 diabetes mellitusDragana Kacarevic, Natasa Bogavac-Stanojevic, Vesna Spasojevic-Kalimanovska, et al.Growth Factors (Chur, Switzerland)|October 19, 2022
Matrine induces hepatocellular carcinoma apoptosis and represses EMT and stemness through microRNA-299-3p/PGAM1 axisBaoLin Wang, HuiHai Wang, Qin Zhao, et al.Growth Factors (Chur, Switzerland)|August 26, 2022
Platelet lysate and tendon healing: comparative analysis of autologous frozen-thawed PRP and ketorolac tromethamine in the treatment of patients with rotator cuff tendinopathyRaha Markazi, Mohammad Sadegh Soltani-Zangbar, Majid Zamani, et al.Growth Factors (Chur, Switzerland)|September 22, 2018
Heterodimeric BMP-2/7 exhibits different osteoinductive effects in human and murine cellsXiao Zhang, Si Chen, Yunsong Liu, et al.Growth Factors (Chur, Switzerland)|July 6, 2019
Bone morphogenetic protein signaling in breast cancer progressionLap Hing Chi, Allan D Burrows, Robin L AndersonGrowth Factors (Chur, Switzerland)|January 1, 1989
Differential inhibition by cyclosporin A reveals two pathways for activation of lymphokine synthesis in T cellsA Kelso, N M GoughGrowth Factors (Chur, Switzerland)|January 1, 1989
Recombinant human müllerian inhibiting substance inhibits epidermal growth factor receptor tyrosine kinaseF G Cigarroa, J P Coughlin, P K Donahoe, et al.Growth Factors (Chur, Switzerland)|August 4, 2012
A high-affinity ErbB4Fc fusion protein is a potent antagonist of heregulin-mediated receptor activationEva J Koziolek, Jacqueline F Donoghue, John D Bentley, et al.Growth Factors (Chur, Switzerland)|August 26, 1998
A Neu differentiation factor (NDF) domain essential for proliferation and alterations in morphology of colonic epithelial cells in vitroJ S Whoriskey, S K Pekar, G S Elliott, et al.Pageof 119